Tari Suprapto, Ph.D., RTTP is currently the Director for Search & Evaluation for Western US and Canada for Novo Nordisk, and also scouted for Elanco Animal Health. Tari has extensive experience in licensing, building and managing strategic alliances as she spent over 15 years commercializing innovations from world-class research institutions including Salk Institute, The Rockefeller University, and Memorial Sloan-Kettering Cancer Center. She also has a strong scientific background evidenced by her Ph.D. in cell biology from The Rockefeller University and an Honors B.A. from Swarthmore College. Tari also serves on several committees and boards for national and regional organizations, and is an advisor to CEO 360 and Founders Corner in San Diego. Most recent previous speaking engagements: Seed Showcase (Jan 2024):"Early Seed Financing: Attracting Investment and Extending Your Runway"; Silicone Zombies/Pepticom panel (Jan 2024): Therapeutics of Tomorrow - ML & AI in Drug Discovery; "How To Build Effective Relationships with Corporate Partners"(AUTM Annual Meeting Feb 2024); "Big Pharma 2024: M & A vs Licensing"(Feb 2024 - BIOCOM Global Life Sciences Partnering Conference); "Navigating Pitfalls & Maximizing Partnering Success"(May 2024 - AUTM Webinar); "Marketing Science to Industry"(May 2024 - OHSU Innovates Day)